• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current know how on the absorb BVS technology: an experts' survey.

作者信息

Cortese Bernardo, Valgimigli Marco

机构信息

Interventional Cardiology, A.O. Fatebenefratelli Milano, Italy.

Thoraxcenter, Rotterdam, Netherlands.

出版信息

Int J Cardiol. 2015 Feb 1;180:203-5. doi: 10.1016/j.ijcard.2014.11.168. Epub 2014 Nov 25.

DOI:10.1016/j.ijcard.2014.11.168
PMID:25463365
Abstract
摘要

相似文献

1
Current know how on the absorb BVS technology: an experts' survey.
Int J Cardiol. 2015 Feb 1;180:203-5. doi: 10.1016/j.ijcard.2014.11.168. Epub 2014 Nov 25.
2
Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution.依维莫司洗脱生物可吸收血管支架（BVS）在单一机构临床应用的初步经验。
Int J Cardiol. 2013 Sep 30;168(2):1536-7. doi: 10.1016/j.ijcard.2012.12.037. Epub 2013 Jan 3.
3
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果：ABSORB 队列 B 试验的光学相干断层成像评估（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
4
Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.真实世界人群中ABSORB生物可吸收血管支架与依维莫司洗脱支架植入早期临床结局的比较
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):E10-5. doi: 10.1002/ccd.25569. Epub 2014 Jul 16.
5
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.ABSORB II 随机对照临床试验：比较 Absorb 依维莫司洗脱生物可吸收血管支架系统与 XIENCE 依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变所致缺血性心脏病患者的安全性、疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2012 Nov;164(5):654-63. doi: 10.1016/j.ahj.2012.08.010.
6
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.依维莫司洗脱生物可吸收血管支架治疗糖尿病患者 1 年的临床结果：ABSORB 和 SPIRIT 试验的汇总分析。
JACC Cardiovasc Interv. 2014 May;7(5):482-93. doi: 10.1016/j.jcin.2014.01.155. Epub 2014 Apr 16.
7
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.光学相干断层成像术对头对头比较金属和生物可吸收依维莫司洗脱支架的新生内膜反应。
JACC Cardiovasc Interv. 2011 Dec;4(12):1271-80. doi: 10.1016/j.jcin.2011.08.016.
8
The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.冠状动脉分叉处的可吸收生物可吸收血管支架：来自实验室测试的观察。
JACC Cardiovasc Interv. 2014 Jan;7(1):81-8. doi: 10.1016/j.jcin.2013.07.013. Epub 2013 Dec 11.
9
Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.用于治疗冠状动脉疾病的生物可吸收支架：现状与未来展望。
Expert Rev Med Devices. 2014 Sep;11(5):467-80. doi: 10.1586/17434440.2014.941812. Epub 2014 Aug 2.
10
Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.药物洗脱生物可吸收冠状动脉支架的现状与未来展望
Future Cardiol. 2014 May;10(3):409-20. doi: 10.2217/fca.14.14.

引用本文的文献

1
Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.生物可吸收冠状动脉支架：植入技巧与技术展望
Methodist Debakey Cardiovasc J. 2018 Jan-Mar;14(1):42-49. doi: 10.14797/mdcj-14-1-42.
2
Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?生物可吸收支架血管成形术后，我们是否应该重新考虑双联抗血小板治疗的持续时间？
J Thorac Dis. 2017 Mar;9(3):417-418. doi: 10.21037/jtd.2017.03.05.
3
Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.
用于冠状动脉狭窄的生物可吸收支架：基于当前研究的时机与方式
Curr Cardiol Rep. 2017 Mar;19(3):27. doi: 10.1007/s11886-017-0836-z.